IN FOCUS FEATURE
Building the World's Best Biomanufacturing Workforce:
Martin Lancaster Honored
FROM OUR WEB SITE
From Our Web Site
FDA Approves Pozen's Treximet Migraine Drug
The combination headache treatment will be produced by GlaxoSmithKline in Zebulon, N.C. Sales revenue for the drug is potentially $1 billion.
Biofuels Center Awards $2.55 Million in Funding
Grants and loans will fund projects in four areas: innovation/research, agriculture, industrial production and workforce development.
BPTC Gets New Name: NCBIOIMPACT
To improve recognition and streamline access to the partnership built to meet the workforce needs of North Carolina's life sciences industry, the North Carolina Biomanufacturing and Pharmaceutical Training Consortium is now NCBIOIMPACT.
Award Launched to Honor Martin Lancaster
The H. Martin Lancaster Biotechnology Faculty of the Year Award was unveiled Tuesday night at the Biotechnology Center. The annual award provides $500 for classroom supplies and equipment for the recipient, who will be one of the N.C. Community College System's biotechnology instructors.
Aldagen Begins Phase III Trial for Cord Blood Transplant Drug
Aldagen Inc., based in Durham, N.C., has begun a Phase III clinical trial of a drug to improve cord blood transplants that treat inherited pediatric metabolic diseases.
Rowan-Cabarrus to Expand Clinical Research Training
Continued growth promised at the North Carolina Research Campus prompts new certification program at RCCC.
Openings Available in Special Topics Teacher Workshops
These three special topics summer teacher workshops, Protein Expression (GFP), Biodiversity and Genomics, are scheduled across North Carolina this summer.
In Focus
Building the World's Best Biotechnology Workforce:
Honoring Martin Lancaster
It started as an associate degree program at Alamance Community College.
It's grown to include the entire North Carolina Community College System, the University of North Carolina System, the North Carolina Biosciences Organization and the North Carolina Biotechnology Center. Funding is provided by the General Assembly and the Golden LEAF Foundation.
It is North Carolina's unparalleled training system for biotechnology workers. This week, the members of this unprecedented partnership spent an evening thanking the man who demonstrated the leadership to make it work.
Read what the state's leaders had to say about retiring N.C. Community College System President Martin Lancaster, view a timeline of biotechnology workforce development efforts or read about the award named in Lancaster's honor.
News from Other Sites
FDA Approval Could Mean Big Paydays for Pozen
Stock prices for the Chapel Hill company are on the rise as its combination treatment for migraines heads to market.
From WRAL LocalTechWire and The Skinny
Tears, Beers as Pozen Gets OK
Company employees anxiously awaited word Tuesday night from the Food and Drug Administration on whether its migraine treatment received approval.
From the (Raleigh) News and Observer
Special Report: Biotech
The Business Journal serving the Greater Triad Area ran a three-story spread in Friday's issue about alternative fuels and biotech leadership. Subscription is required to read the full text.
Fueled by opportunities
Researcher's work could use alternative fuels
Recruits bridge management gap as biotechnology base matures
New Ideas Compete in Charlotte
Winners were announced for the Five Ventures Business Plan Competition last week.
From the University of North Carolina at Charlotte
Consumers Flock to Quintiles' Drug Alert Site
Drug safety concerns are fueling the growth of iGuard, a Web site started by RTP-based Quintiles last year.
From the (Raleigh) News and Observer
Community Watch
- Michael Goodman has joined AVOS Life Sciences, an advisory and research products firm with headquarters in Morrisville, as vice president. Goodman, formerly of Cambridge Healthtech Institute, will lead the firm's focus on research products and subscription-based research. More.
- Durham-based Phase BioScience has hired Christopher Prior as its new CEO to succeed Thomas Laundon. Laundon, a former vice president of business and technology development at the North Carolina Biotechnology Center, had been serving as interim CEO. More.
- Oren Cohen, M.D., chief medical and scientific officer for Quintiles Transnational of Research Triangle Park, has been promoted to senior vice president, clinical research strategies. He also will continue to serve as managing director of Quintiles Public Health and Government Services. More.
Please send Community Watch items to Jim Shamp.
Save the Date
May 9
Biofuels Center Opening
(Oxford)
May 19-20
Biotech 2008
(Winston-Salem)
June 17-20
BIO 2008 Conference
NC Pavilion Sponsorship
(San Diego)
Dec. 4-5
SE Bio Investor Forum
(Palm Beach, Fla.)
View our complete listing of events across North Carolina.
This newsletter was sent Thursday, Apr. 17, 2008. For the latest North Carolina biotechnology industry headlines, please visit the news section of our Web site.
Online subscription management is now available. Please respond to this e-mail if you cannot change your preferences online.